AminoAnalytica

Name: AminoAnalytica
Brand: AminoAnalytica

AI Native

Autonomous protein design.

Est 2024|Raised $500K

LinkedIn 1K|Website|FTEs 4|HQ San Francisco, California, US

Published Sep 19, 2026

01Common complaints

- Enterprise procurement that requires immediate access to SOC 2/ISO reports and public audit attestations: the vendor does not publicly publish these at the time of review and may be unable to meet procurement gates without additional contractual engagement. - Organizations seeking a full R&D data management system (ELN/LIMS/registry) as their system of record: platforms focused on ELN/LIMS are better suited for system-of-record requirements. - Teams with established internal protein-design infrastructure and reproducible pipelines running on private HPC with formal provenance: the incremental benefit of migrating to a packaged platform may be limited. - Work that depends on proprietary or closed-source tools not listed as supported by the vendor: the vendor indicates focus on commercially available open-source tools, which may exclude licensed toolchains. - Groups with budgets highly sensitive to iterative compute consumption and without guardrails for automated workflows: pay-as-you-go compute models can increase costs for heavy iterative workloads.

Deal disqualifiers (poor fit)

Strict data residency or sovereignty requirements without contractual support
Immediate procurement requirements for validated compliance attestations (for example, SOC 2) that are not available
Highly proprietary pipelines requiring internal-only execution and full control over toolchains

Publicly acknowledged limitations

Tool availability: tools not present on the platform must be requested; the vendor indicates current focus on commercially available open-source tools.

Likely limitations to verify during evaluation

- Version pinning and reproducibility controls across the catalog of integrated tools. - API maturity for automation, export, and integration with internal systems. - Details of collaboration features (for example, projects, granular permissions, and shared workspaces) — enterprise features are mentioned but not fully documented publicly. - Data deletion and retention policies beyond simple account deletion instructions; buyers should request explicit SLAs and deletion procedures.

02Why they buy

Unique selling points that are supported by available descriptions

A packaged orchestration layer combined with on-demand compute accessible via web UI, chat assistant, and CLI.
Vendor statements that the platform integrates a broad set of commonly used protein engineering tools (vendor-cited 50+ tools).
Reduced initial setup effort relative to assembling and maintaining local toolchains and GPU infrastructure.

Unique selling points that require validation

Vendor claims of large speed and labor-efficiency improvements are plausible in some scenarios but lack publicly disclosed benchmarks or customer case studies.
Claims about compute pricing (for example, no markup) require verification against the buyer's usage patterns and disclosed GPU types.

03Field reports

Review-platform availability (G2, TrustRadius, Gartner Peer Insights)

Attempts to identify product-specific listings on major review platforms returned either no accessible product page or were blocked by access restrictions on certain sites. There were no substantive, accessible collections of third-party customer reviews for AminoAnalytica identified during this review.

This lack of coverage suggests the product is early-stage and has limited presence on mainstream review platforms.

Community/social proof (YC and vendor statements)

Public company profiles such as the Y Combinator company page and vendor statements provide promotional descriptions and founder commentary. These materials are vendor-originated and should be treated as marketing content rather than independent testimonial evidence.

Vendor-presented claims include examples of speed and labor-efficiency improvements; these are vendor statements without independent benchmarking or customer references.

Reddit / community discussions

Searches returned name collisions with unrelated topics (for example, general "amino" discussions). No substantive, product-specific community feedback threads were identified in accessible forums.

Reasons customers may select AminoAnalytica (inferred)

Need for a preconfigured environment for common protein design tools that reduces DevOps work.
Requirement for elastic, on-demand GPU compute to support bursty workloads.
Preference for automated orchestration of toolchains rather than manual chaining of separate tools.

Reasons customers might avoid or discontinue use (inferred from buyer concerns)

Insufficient publicly documented security and compliance information for enterprise procurement.
Preference among scientists for internally curated pipelines to maintain reproducibility and control.
Limitations in tool availability or integration capabilities for existing workflows.

Public case studies

No first-party case studies naming customers and providing quantified outcomes were identified in accessible first-party materials.

Vendor examples (non-independent)

The vendor provides illustrative cost and time examples (for instance, an example showing a short fold run with a nominal per-run cost), but these are demonstrations rather than independently validated case studies and do not specify workload assumptions or overhead. Recommendation for buyers: request a pilot that includes a defined benchmark suite (the buyer's proteins and constraints), explicit success metrics (time-to-result, hit quality, reproducibility), and an agreed cost ceiling with transparent reporting.

04Best fit

Company sizes

Likely best fit:
- Startups and small biotech teams (small organizations)
- R&D teams with a small computational staff capable of validating outputs
Potential fit (with expanded enterprise features): mid-market biotech organizations with platform teams

Industries / verticals

Biotherapeutics (protein biologics such as antibodies, enzymes)
Synthetic biology
Industrial biotech (enzymes for materials, food, chemicals)
Academic research labs (subject to vendor pricing and data policies)

Roles and personas

Decision makers: Head/Director of Protein Engineering, VP R&D, CTO
Champions: senior computational protein engineer, bioinformatics lead
Influencers: IT/security, data platform owner, legal/procurement

Pain points addressed

Tool fragmentation and maintenance burden
Delays in GPU and resource provisioning
Need for faster, iterative exploration of candidate sequences

Qualification criteria (good fit)

Workloads that rely on commonly used open-source or commercially available open tools (for example, RFdiffusion, ProteinMPNN, ESM-style workflows)
Comfort with cloud execution and sharing sequences with a vendor platform under acceptable contractual terms
Need for rapid experimentation rather than deep custom method development and tightly controlled provenance

05The pitch

What the product does (core value proposition)

AminoAnalytica offers Amina, a platform for protein engineering workflows that coordinates common computational steps (for example, generative design, folding/structure prediction, docking/characterization). The platform provides a web interface that does not require scripting, a chat-style assistant, and a command-line interface. The vendor positions the platform as reducing setup and infrastructure requirements (no local tool compilation or GPU provisioning) and enabling faster iteration by chaining multiple tools into an integrated workflow. Vendor statements reference substantial speed and labor efficiency gains (for example, claims of orders-of-magnitude speedups and that fewer engineers can achieve the output of a larger team), but these assertions are presented as vendor marketing and lack publicly disclosed benchmarking methodology or independent validation.

Target market and market positioning

- Primary users: computational protein engineers, bioinformaticians, and protein design scientists in biotech/pharma, synthetic biology, and academic labs. - Positioning: a workflow and orchestration layer combined with on-demand GPU compute for protein design tooling; functions as a platform or operations layer rather than a single, proprietary predictive model. - Buying center: R&D leadership (VP R&D, Head of Protein Engineering), computational biology leads, and platform engineering/IT for enterprise rollouts.

Get a comprehensive analysis of AminoAnalytica including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →

Published Sep 19, 2026

01Common complaints

Enterprise procurement that requires immediate access to SOC 2/ISO reports and public audit attestations: the vendor does not publicly publish these at the time of review and may be unable to meet procurement gates without additional contractual engagement.
Organizations seeking a full R&D data management system (ELN/LIMS/registry) as their system of record: platforms focused on ELN/LIMS are better suited for system-of-record requirements.
Teams with established internal protein-design infrastructure and reproducible pipelines running on private HPC with formal provenance: the incremental benefit of migrating to a packaged platform may be limited.
Work that depends on proprietary or closed-source tools not listed as supported by the vendor: the vendor indicates focus on commercially available open-source tools, which may exclude licensed toolchains.
Groups with budgets highly sensitive to iterative compute consumption and without guardrails for automated workflows: pay-as-you-go compute models can increase costs for heavy iterative workloads.

Deal disqualifiers (poor fit)

Strict data residency or sovereignty requirements without contractual support
Immediate procurement requirements for validated compliance attestations (for example, SOC 2) that are not available
Highly proprietary pipelines requiring internal-only execution and full control over toolchains

Publicly acknowledged limitations

Tool availability: tools not present on the platform must be requested; the vendor indicates current focus on commercially available open-source tools.

Likely limitations to verify during evaluation

Version pinning and reproducibility controls across the catalog of integrated tools.
API maturity for automation, export, and integration with internal systems.
Details of collaboration features (for example, projects, granular permissions, and shared workspaces) — enterprise features are mentioned but not fully documented publicly.
Data deletion and retention policies beyond simple account deletion instructions; buyers should request explicit SLAs and deletion procedures.

02Why they buy

Unique selling points that are supported by available descriptions

A packaged orchestration layer combined with on-demand compute accessible via web UI, chat assistant, and CLI.
Vendor statements that the platform integrates a broad set of commonly used protein engineering tools (vendor-cited 50+ tools).
Reduced initial setup effort relative to assembling and maintaining local toolchains and GPU infrastructure.

Unique selling points that require validation

Vendor claims of large speed and labor-efficiency improvements are plausible in some scenarios but lack publicly disclosed benchmarks or customer case studies.
Claims about compute pricing (for example, no markup) require verification against the buyer's usage patterns and disclosed GPU types.

03Field reports

Review-platform availability (G2, TrustRadius, Gartner Peer Insights)

Attempts to identify product-specific listings on major review platforms returned either no accessible product page or were blocked by access restrictions on certain sites. There were no substantive, accessible collections of third-party customer reviews for AminoAnalytica identified during this review.

This lack of coverage suggests the product is early-stage and has limited presence on mainstream review platforms.

Community/social proof (YC and vendor statements)

Public company profiles such as the Y Combinator company page and vendor statements provide promotional descriptions and founder commentary. These materials are vendor-originated and should be treated as marketing content rather than independent testimonial evidence.

Vendor-presented claims include examples of speed and labor-efficiency improvements; these are vendor statements without independent benchmarking or customer references.

Reddit / community discussions

Searches returned name collisions with unrelated topics (for example, general "amino" discussions). No substantive, product-specific community feedback threads were identified in accessible forums.

Reasons customers may select AminoAnalytica (inferred)

Need for a preconfigured environment for common protein design tools that reduces DevOps work.
Requirement for elastic, on-demand GPU compute to support bursty workloads.
Preference for automated orchestration of toolchains rather than manual chaining of separate tools.

Reasons customers might avoid or discontinue use (inferred from buyer concerns)

Insufficient publicly documented security and compliance information for enterprise procurement.
Preference among scientists for internally curated pipelines to maintain reproducibility and control.
Limitations in tool availability or integration capabilities for existing workflows.

Public case studies

No first-party case studies naming customers and providing quantified outcomes were identified in accessible first-party materials.

Vendor examples (non-independent)

Recommendation for buyers: request a pilot that includes a defined benchmark suite (the buyer's proteins and constraints), explicit success metrics (time-to-result, hit quality, reproducibility), and an agreed cost ceiling with transparent reporting.

04Best fit

Company sizes

Likely best fit:
- Startups and small biotech teams (small organizations)
- R&D teams with a small computational staff capable of validating outputs
Potential fit (with expanded enterprise features): mid-market biotech organizations with platform teams

Industries / verticals

Biotherapeutics (protein biologics such as antibodies, enzymes)
Synthetic biology
Industrial biotech (enzymes for materials, food, chemicals)
Academic research labs (subject to vendor pricing and data policies)

Roles and personas

Decision makers: Head/Director of Protein Engineering, VP R&D, CTO
Champions: senior computational protein engineer, bioinformatics lead
Influencers: IT/security, data platform owner, legal/procurement

Pain points addressed

Tool fragmentation and maintenance burden
Delays in GPU and resource provisioning
Need for faster, iterative exploration of candidate sequences

Qualification criteria (good fit)

Workloads that rely on commonly used open-source or commercially available open tools (for example, RFdiffusion, ProteinMPNN, ESM-style workflows)
Comfort with cloud execution and sharing sequences with a vendor platform under acceptable contractual terms
Need for rapid experimentation rather than deep custom method development and tightly controlled provenance

05The pitch

What the product does (core value proposition)

Vendor statements reference substantial speed and labor efficiency gains (for example, claims of orders-of-magnitude speedups and that fewer engineers can achieve the output of a larger team), but these assertions are presented as vendor marketing and lack publicly disclosed benchmarking methodology or independent validation.

Target market and market positioning

Primary users: computational protein engineers, bioinformaticians, and protein design scientists in biotech/pharma, synthetic biology, and academic labs.
Positioning: a workflow and orchestration layer combined with on-demand GPU compute for protein design tooling; functions as a platform or operations layer rather than a single, proprietary predictive model.
Buying center: R&D leadership (VP R&D, Head of Protein Engineering), computational biology leads, and platform engineering/IT for enterprise rollouts.

Get a comprehensive analysis of AminoAnalytica including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →